Skip to content
TLexDR

Manolis Kellis: Biology of Disease

10-25-20 ▶ 2h 34m 📖 5 min read
Core Takeaways
Manolis Kellis argues that understanding human disease requires embracing the complexity of genetic variants beyond protein-coding genes.
Why it matters This complexity suggests that disease treatment must consider non-coding regions, which constitute 98.5% of the genome.
CRISPR technology revolutionizes genome editing by simplifying the guiding process, not the cutting or fixing. ▶ 19:20
Why it matters CRISPR's ease of use accelerates genetic research and therapeutic development by allowing precise edits.
The FTO gene, once misunderstood, is linked to obesity through distant gene regulation involving IRX3 and IRX5. ▶ 1:10:30
Why it matters Understanding FTO's true role opens pathways for targeted obesity interventions, correcting past misconceptions.
Alzheimer's disease genetics indicate significant roles for microglia, not neurons or astrocytes, in disease progression. ▶ 2:05:00
Why it matters Targeting microglia could lead to novel Alzheimer's treatments, shifting focus from traditional neuron-centric approaches.

How the conversation moved

The episode begins with Lex framing the challenge of understanding human disease through the lens of genetic complexity, as Manolis Kellis describes the vast number of genetic…

Ask this episode Deep

A preview of how Deep chat answers, grounded in this episode with citations and timestamps:

Cite this episode

For papers, blog posts, anywhere.

Copied!

Related episodes

Where to go next from this conversation.

AI-generated summary · last refreshed 2026-06-06 22:03:41 · how we make these

Quotes are matched verbatim against the source transcript; references are checked to resolve to real URLs. Even so, AI can misread structure or attribute claims imperfectly. If you spot an error, please let us know.

Report an inaccuracy →